Preteen and teen vaccines: what to do with the recent recommendations
|
|
- Loreen Washington
- 6 years ago
- Views:
Transcription
1 Preteen and teen vaccines: what to do with the recent recommendations MARK H. SAWYER UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO Continuing Education The Illinois Chapter, American Academy of Pediatrics is accredited by the Illinois State Medical Society (ISMS) to provide continuing medical education for physicians. The Illinois Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s). 2 1
2 Disclosures I have no financial disclosures related to this presentation 3 Objectives List the factors influencing recommendations for serogroup B meningococcal vaccines so that you can decide how to use them Describe the added benefits of HPV9 vaccine so that you can advise your patients about whether they should receive it Explain the changes in recommendations for use of influenza vaccine in eggallergic patients so that you can educate your patients Explain why we are seeing so much pertussis and why there is not a recommendation to give Tdap boosters in the general population Describe which of your teenage patients should receive PCV13 vaccine so that you are sure to immunize them 4 2
3 Meningococcal Disease, College Outbreaks, Meningococcal B Vaccine Meningococcal Disease Five main strains of Neisseria meningitidis (Meningococcus): A, B, C, Y, W The previously licensed meningococcal vaccines contain serogroup A, C, Y, W Serogroups B, C and Y circulate in the United States Serogroup B disease is common in young children and becoming more common in adolescents and adults Outbreaks of meningococcal type B at Princeton and UCSB in 2014; University of Oregon in 2015; Santa Clara University 2016 N. meningitidis causes overwhelming sepsis and meningitis with a high mortality rate (approx 10%) 3
4 Meningococcal serogroup B vaccines First serogroup B membrane protein vaccine licensed in October MenB-FHbp (Trumenba). fhbp subfamily A/v2,3; subfamily B/v1. A 3-dose vaccine Second serogroup B membrane protein vaccine licensed in January MenB-4C (Bexero). fhbp subfamily B/v1, NhbA, NadA, Por A1.4. A 2-dose vaccine. Licensed in >30 countries Use in high-risk patients recommended by ACIP in February 2015 Permissive recommendations for use in general population in June 2015 These are different vaccines from the ACWY vaccines and different from each other. They cannot be used interchangeably So we should start giving all adolescents Meningococcal B vaccine, right? It s not so simple! 4
5 MacNeil-ACIP October 2014; MacNeil-ACIP October 2014; 5
6 Should we immunize all adolescents to prevent a very small number of cases and deaths? MacNeil-ACIP October 2014; 6
7 Patel-ACIP October 2014 Immunogenicity Summary Demonstrated immune response in general adolescent population 86-98% achieved protective antibody titers after 3 doses of MenB-FHbp [US adolescents and young adults] % for achieved protective antibody titers after 2 doses of MenB-4C [Chilean and UK adolescents and young adults] 73-93% [US and Polish adolescents and young adults] Data not directly comparable between the 2 vaccines Immunogenicity data not currently available in groups at increased risk Limited short-term (18-23 months) antibody persistence data available for MenB-4C Patel-ACIP October
8 MenB-FHbp MenB-4C Serogroup B Meningococcal Vaccine Recommendations for High Risk A serogroup B meningococcal vaccine (MenB) series should be administered to persons aged >10 years at increased risk for meningococcal disease (Category A). This includes: Persons with persistent complement component deficiencies, including those taking eculizomab. Persons with anatomic or functional asplenia including those with sickle cell disease Microbiologists routinely exposed to isolates of Neisseria meningitides Persons identified as being at risk due to a serogroup B meningococcal outbreak MMWR, 2015;64: 608 8
9 MMWR, 2015;64: 608 What about everyone else? A Men B vaccine series MAY be administered to adolescents and young adults aged years to provide SHORT-TERM protection against MOST strains of serogroup B meningococcal disease. The preferred age for Men B vaccination is years. Macneil J, ACIP presentation June
10 Meningococcal B Vaccines: Who should you give them to? year olds who request it Those living in dormitories or other crowded conditions? Kids whose college or other institution requires it Those who smoke or drink alcohol???? Three reasons you should care about HPV vaccine HPV causes lots of cancer HPV vaccine prevents cancer We are doing a terrible job of immunizing our population with HPV vaccine to prevent cancer 10
11 HPV infection causes lots of cancer HPV vaccine-infection reduction since vaccine became available-females 64% reduction in prevalence of 4vHPV type infection in 14-19yo 34% reduction in yo No reduction in >24yo populations No change in prevalence of non-vaccine serotypes Achieved with only 34% 3-dose vaccine coverage Markowitz-Pediatrics 2016:137(2): e
12 Prevalence per 1000 Person-years 3/22/2016 Anogenital Wart Prevalence per 1000 person-years, US Private Insurance Enrollees, by Age, Females Males Flagg, et al. AJPH HPV vaccine coverage rates-united States MMWR July 31, 2015 / 64(29);
13 We are part of the problem Allison MA et al. Pediatrics 2016;137(2):e HPV9 vaccine is here Previous HPV vaccines contain two (2vHPV[types 16 and 18], Cervarix) or four (4vHPV[types 6, 11, 16, 18], Gardasil) serotypes HPV serotypes 16 and 18 are in both vaccines and are the most common causes of cervical cancer HPV serotypes 6 and 11 are only in HPV4 A new vaccine with 9 HPV serotypes is now available-adds types 31, 33, 45, 52, 58 Recommended routinely beginning at 11 years of age 13
14 HPV Immunization Recommendations Routine immunization at age years for all. Start using HPV9 All Females aged years. Can complete the series with HPV9 All Males aged years. Can complete the series with HPV9 but less benefit Men who have sex with men aged years. Can complete the series with HPV9 but less benefit MMWR 2015; 64: ; CDC.gov 14
15 Should I revaccinate teens who have already completed an HPV vaccine series? No routine recommendation to revaccinate those who have already completed a series Lack of a recommendation is based largely on a cost-benefit assessment Focus is on just getting 3 doses into all teens No safety concerns identified with revaccination Will increase cancer prevention May not be covered by insurance MMWR 2015; 64: ; CDC.gov Questions You Hear about Pertussis Immunization Why are we seeing so much pertussis? Does vaccine immunity wane quickly? Does Tdap vaccine immunity wane as fast as DTaP vaccine immunity Was DTP a better vaccine than DTaP? Are circulating strains mutating (e.g., pertactin deficient strains) How are we doing with DTaP and Tdap vaccine coverage? Is Tdap vaccine safe in pregnancy? Should we be giving Tdap boosters?
16 Pertussis in California Reasons for Outbreaks of Pertussis Pertussis is very contagious People who have pertussis can be contagious for up to 3 weeks Pertussis is difficult to recognize and diagnose Even after someone begins treatment for pertussis they are contagious for up to 5 days Immunity from prior vaccination or disease wanes over time so people become susceptible again
17 Evidence of decreased protection in adolescent immunized with acellular vaccines as infants Klein NP et al. Pediatrics, 2016;137(3):e Tdap Vaccine Effectiveness Koepke R, J Infect Dis 2014;210:
18 Tdap Vaccine Effectiveness Klein NP et al. Pediatrics, 2016;137(3):e Prepared by County of San Diego, Health & Human Services Agency, Public Health Services, Epidemiology & Immunization Services, 9/4/
19 Why Immunize at Every Pregnancy? 37 Tom Clark, CDC, ACIP presentation Feb
20 Tdap during pregnancy works! Dabrera G, Clin Infect Dis 2015;60(3):333-7 Should we give Tdap Boosters? Tdap boosters have been considered based on waning immunity Interval between Tdap vaccines uncertain Cost-benefit is poor Growing experience in Canada, Australia, and other countries with a 10 year interval Limited experience with a 5 year interval Stay tuned
21 Effect of Tdap boosters at 16 or 21 years of age Kamiya et al, Vaccine 2016 Feb 17. pii:s x(16) Tdap Recommendations CDC/AAP/AAFP/ACOG/ACP Routine use at years of age Replace Td for all ages Special focus on adults in contact with young infants Pregnant women-primary strategy for preventing severe disease Healthcare providers Parents and siblings Grandparents (including those >64 years of age) No booster except for pregnant women
22 Influenza :it wasn t a very good year has been better 22
23 Interim Influenza Vaccine Effectiveness Overall=59% (44-70) Influenza A H1N1=51% (25-69) Influenza A H3N2-insufficient data Influenza B=76% (59-89) LAIV=????????????? ACIP meeting, February 2016; Influenza vaccine New Influenza A (H3N2) strain based on minor changes in circulating strains New Influenza B strain for the trivalent vaccine Quadrivalent vaccine contains both Influenza B strains Both trivalent and quadrivalent vaccines will be available FDA VRBPAC Meeting March 4,
24 Influenza vaccine and egg allergy-stop worrying! Current manufacturing techniques have lowered the amount of ovalbumin contained in influenza vaccines to a very low amount Multiple studies have now shown that severe reactions to influenza vaccine among egg allergic individuals is exceedingly rare and no more likely than in the general population Any influenza vaccine product can be given to egg allergic individuals-including those who have had anaphylaxis to egg. Includes LAIV You should be just as prepared to treat an anaphylactic reaction to influenza vaccine as you are for any other vaccine 30 minute waiting period dropped to 15 minutes ACIP meeting, February 2016; Pneumococcal conjugate vaccine (PCV13) for older children 24
25 Pneumococcal Vaccines POLYSACCHARIDE-PPSV23 PROTEIN CONJUGATE VACCINE- PCV13 Pneunovax Available for decades Used in high risk populations including all adults >65 years of age Immunity wanes so some groups need a repeat dose 5 years after their first PPSV23 Only limited benefit from repeated doses Prevnar 13 Induces a better immune response Began using PCV7 routinely in young children in the 1990 s PCV13 became available in 2010 Has led to reduced disease even in unimmunized populations Licensed for adults >50 years of age in Two populations should receive both PCV13 and PPSV23 HIGH RISK CHILDREN AND ADULTS ALL ADULTS 65 YEARS AND OLDER Immunocompromised (e.g. HIV, malignancy) Anatomic or functional asplenia Cochlear implants CSF leaks Nephrotic syndrome 25
26 Pneumococcal vaccine: PCV 13 for 6 through 18 year old children at increased risk Risk groups Immunocompromised (malignancy, HIV infection, asplenia, chronic renal failure) CSF leaks Cochlear implants These groups need both conjugate (PCV13-Prevnar) and polysaccharide (PPSV23-Pneumovax) Immunologic response best if PCV given prior to PPSV23 8 weeks currently recommended between vaccines PPSV recommendations have not changed Pediatrics 2014;134: Pediatrics 2014;134:
27 Take Home Points Serogroup B meningococcal vaccine now available. Recommendations for use currently limited. New HPV9 vaccine available. Should be given to all year old children. Limited role for reimmunizing those who have already received HPV2 or HPV4. We need to do a better job of delivering HPV vaccine to adolescents. Pertussis remains a big problem in large part due to waning vaccine immunity. Focus on immunizing pregnant women at every pregnancy Egg allergic individuals can receive any influenza vaccine safely PCV13 now indicated for high-risk older children 53 Information for Health-Care Professionals NNII ( VEC ( IAC ( CDC/NIP ( AAP ( AAFP ( IVS ( Vaccine Page ( Every Child by Two ( CDPH.gov (shot for shot) PKIDS ( 27
Welcome to the California Immunization Coalition Education Hour
Welcome to the California Immunization Coalition Education Hour 1 . Implementing a System-Wide Immunization Requirement at the University of California Webinar Objectives Describe the rationale and purpose
More informationVACCINES-WHAT HAS HAPPENED IN THE LAST YEAR. Mark H. Sawyer UCSD School of Medicine Rady Children s Hospital San Diego
VACCINES-WHAT HAS HAPPENED IN THE LAST YEAR Mark H. Sawyer UCSD School of Medicine Rady Children s Hospital San Diego LOTS HAS HAPPENED AND IT CAN BE A LITTLE CONFUSING Some people can get 2 doses of HPV
More informationVaccines for infants- What has happened in the last year?
Vaccines for infants- What has happened in the last year? MARK H. SAWYER UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO Lots has happened and it can be a little confusing Infants used to require
More informationImmunization Update Tamara Sheffield, MD, MPA, MPH
Immunization Update 2015 Tamara Sheffield, MD, MPA, MPH Disclosure I do not have any relevant financial relationships with any commercial interests I am a Medical Director employed by Intermountain Healthcare
More informationACIP Recommendation Update. Mark H. Sawyer, MD UCSD School of Medicine Rady Children s Hospital San Diego
ACIP Recommendation Update Mark H. Sawyer, MD UCSD School of Medicine Rady Children s Hospital San Diego What has ACIP been up to lately? New Recommendations Tdap vaccination for each pregnancy Meningococcal
More informationImmunization Update 2015
Immunization Update 2015 William Atkinson, MD, MPH Immunization Action Coalition Kentucky Immunization Conference Louisville, Kentucky October 14, 2015 Information in this presentation are valid as of
More informationWhose Calling the Shots? - A 2019 Vaccine Update. Frank Bell Swedish Pediatric Infectious Disease Jan 2019
Whose Calling the Shots? - A 2019 Vaccine Update Frank Bell Swedish Pediatric Infectious Disease Jan 2019 2019 Vaccine Update Vaccines Meningococcal serogroup B HPV Pertussis Influenza Children with uncertain
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationVaccinations for Adults
Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and
More informationAdolescent Immunizations
Adolescent Immunizations Preteen Vaccine Week Webinar January 23, 2008 Eileen Yamada, MD, MPH California Department of Public Health Immunization Branch Younger Children AND Adolescents Need Immunizations!
More informationImmunization Update 2015
Immunization Update 2015 William Atkinson, MD, MPH* California Immunization Coalition Summit Riverside, California April 26, 2015 *Representing the Immunization Action Coalition, Saint Paul, MN Advisory
More informationAndrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010
2010 Immunization Update Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010 Disclosures No financial conflict
More informationUpdate on Vaccine Recommendations. Objectives. Childhood Immunization Schedule At the Turn of the Century. New Horizons in Pediatrics April 30, 2017
Centers for for Disease Disease Control Control and and Prevention Prevention National Center for Immunization and Respiratory Diseases Update on Vaccine Recommendations New Horizons in Pediatrics April
More informationNothing to disclose.
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More informationObjectives 1. Become familiar with current immunization schedules for children
Sarah Matches, DO, FAAP Assistant Professor UNTHSC, Dept. of Pediatrics Objectives 1. Become familiar with current immunization schedules for children 2. Describe the international progress in reducing
More informationWHAT S NEW WITH VACCINATIONS IN 2016?
WHAT S NEW WITH VACCINATIONS IN 2016? MenB and a Few Other Changes Lynn Bahta, RN, PHN Immunization Clinical Consultant Minnesota Department of Health May 2016 Disclosure No conflict of interest Will discuss
More informationHemagglutinin Neuraminidase
Evolving Vaccine Guidance: Influenza, Meningococcal & HPV Vaccines H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Maine Chapter AAP Bar Harbor, Maine October 16, 2016
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Outline vaccines to be covered
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationSeries of 2 doses, 6-12 months apart. One dose is 720 Elu/0.5ml (GSK) or 25 u/0.5 ml (Merck)
UTAH PREVENTIVE CARE RECOMMENDATIONS Adult - Ages 19 and Above IMMUNIZATIONS CONTENTS: General Instructions Hepatitis A Hepatitis B Human Papilloma Virus Influenza Meningococcal A, C, Y, W (MCV4) Meningococcal
More information2015 ACIP Immunization Schedules & Recommendations and MDPH Updates
Massachusetts Department of Public Health Division of Epidemiology and Immunization 2015 ACIP Immunization Schedules & Recommendations and MDPH Updates Susan M. Lett, MD, MPH Medical Director, Immunization
More information! Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted
Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital! Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted! Traditionally
More informationImmunization Update. William Atkinson, MD, MPH. Immunization Action Coalition
Immunization Update William Atkinson, MD, MPH Immunization Action Coalition Coordinated School Health Conference Lake Ozark, Missouri December 3, 2016 1 Disclosures William Atkinson has no financial relationships
More informationImmunization Update 2016 Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH
Immunization Update 2016 Clinical Learning Day Tamara Sheffield, MD, MPA, MPH Disclosure I do not have any relevant financial relationships with any commercial interests I am a Medical Director employed
More information2017 Vaccination Update
2017 Vaccination Update NATHAN BOONSTRA, MD General Pediatrician, Blank Pediatric Clinic TODAY S OBJECTIVES Review the latest recommendations for immunizations, including HPV Meningococcal vaccines Influenza
More information2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS
IMMUNIZATION UPDATE 2015 Kelly Ridgway, RPh February 21, 2015 Today s Overview 1 2 3 4 5 6 Pneumococcal Vaccine Recommendations Meningococcal Vaccine Recommendations HPV Vaccine Recommendations Patient
More informationPlatforms. Adolescent Immunization Update and the 16 Year Old Platform. Advisory Committee on Immunization Practices (ACIP)
Adolescent Immunization Update and the 16 Year Old Platform William Atkinson, MD, MPH Associate Director for Immunization Education Immunization Action Coalition Advisory Committee on Immunization Practices
More informationImmunization Update Disclosures. Candice Robinson, MD, MPH Medical Officer Immunization Services Division 5/12/2017
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Immunization Update 2017 Candice Robinson, MD, MPH Medical Officer Immunization Services Division Western
More informationImmunization Update for Health System Pharmacists Eric Crumbaugh, PharmD
Immunization Update for Health System Pharmacists 2015 Eric Crumbaugh, PharmD Financial Disclosures Eric Crumbaugh, PharmD Speaker s Bureau Merck Vaccines Pfizer Consultant Pfizer Novartis Merck Objectives
More informationHIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS. Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan
HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan DISCLOSURES No financial or other conflicts to disclose LEARNING OBJECTIVES
More informationImmunizations. Update Immunizations through Time. Learning Objectives. Presenter Disclosure Information. 10:30 11:45am. Immunization Update
10:30 11:45am Immunization Update SPEAKER John Russell, MD Presenter Disclosure Information The following relationships exist related to this presentation: John Russell, MD, serves on Speaker s Bureau
More informationThese slides are the property of the presenter. Do not duplicate without express written consent.
Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS) loynesh@michigan.gov Are Vaccine-Preventable
More informationImmunization Update 2017 Adult Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH
Immunization Update 2017 Adult Clinical Learning Day Tamara Sheffield, MD, MPA, MPH Highlighted Topics Influenza Vaccine Errors 2 Dose HPV Community protection Tdap in pregnancy Meningococcal Future Recs
More information7/13/2016. Immunization Update Disclosures. Objectives. No financial disclosures to report
Immunization Update 2016 Courtney A. Robertson, PharmD Clinical Assistant Professor University of Louisiana at Monroe School of Pharmacy Disclosures No financial disclosures to report Objectives Pharmacists
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationRecommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016 This schedule includes recommendations in effect as of January 1, 2016. Any dose not administered at the recommended
More informationNothing to disclose.
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More informationDisclosures. Potential conflicts. No off-label use discussion. Safety Review Committee. Data and Safety Monitoring Board
2016 Vaccine Update Clinical Reviews Rochester, Minnesota November 2 and November 16, 2016 Robert M Jacobson, MD, FAAP Medical Director, Mayo Clinic Primary Care Immunization Program Disclosures Potential
More information4/7/2017. Audrey Ofir, MD, MBA, FAAP University of Miami Miller School of Medicine Holtz Children Hospital
Audrey Ofir, MD, MBA, FAAP University of Miami Miller School of Medicine Holtz Children Hospital 1 9vHPV Tdap MCV LAIV HepB Children with Medical conditions 2 9vHPV vaccine HPV infection: Causes cervical,
More informationImmunization Recommendations for College Students
May 2017 ACHA Guidelines Immunization Recommendations for College Students Immunizations offer safe and effective protection from vaccine-preventable diseases and outbreaks. The United States is experiencing
More informationVaccines, Not Just for Babies
Vaccines, Not Just for Babies Meg Fisher, MD Medical Director Disclosures I have no relevant financial relationships with the manufacturers of any commercial products or commercial services discussed in
More informationImmunization Update Clark Kebodeaux, Pharm.D., BCACP
Immunization Update 2015 Clark Kebodeaux, Pharm.D., BCACP Objectives Describe the Advisory Committee on Immunization Practices (ACIP) recommendations and updates for 2014/2015 that guide current immunization
More informationImmunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR
Immunizations June 5, 2015 Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR Disclosures None Goals Understand basic public health impact of immunization Recognize types
More informationNeedle Facts: Immunization Update Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy
Needle Facts: Immunization Update 2015 Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy Objectives Pharmacists At the conclusion of this program, the pharmacist will be able
More informationImmunization-Preventable Outbreaks, Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Health Care Agency May 5, 2014
Immunization-Preventable Outbreaks, 2014 Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Health Care Agency May 5, 2014 Outbreaks to Cover Meningococcus group B Pertussis Mumps
More informationImmunization Update 2017 Peds Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH
Immunization Update 2017 Peds Clinical Learning Day Tamara Sheffield, MD, MPA, MPH Highlighted Topics Influenza Vaccine Errors 2 Dose HPV Community protection Tdap in pregnancy Hepatitis B Meningococcal
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Preventative Vaccines
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Preventative Vaccines Diseases/Pathogens
More informationImmunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012
Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants
More informationImmunization Update 2015
Immunization Update 2015 JoEllen Wolicki BSN, RN Immunization Services Division National Center for Immunization and Respiratory Diseases Tennessee Annual Spring Immunization Review April 2015 National
More informationDeclarations. Objectives At the end of this presentation participants will be 7/25/2017. Dr. Mary Koslap Petraco has nothing to declare
Mary Koslap Petraco DNP, PNP BC, CPNP, FAANP Nurse Consultant Immunization Action Coalition Stony Brook University School of Nursing The Nurse Practitioner Association New York State 33 rd Annual Conference
More informationPoint/Counterpoint. Mia A. Taormina, DO, FACOI MarkAlain Dery, DO, FACOI
Point/Counterpoint Mia A. Taormina, DO, FACOI MarkAlain Dery, DO, FACOI It s Influenza Season A couple in their 40s comes to your clinic in early August and asks about influenza vaccine. It is being offered
More information3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationVaccinations for Adults and Adolescents: An Update
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More information21 st Century Vaccine Challenges
21 st Century Vaccine Challenges Presentation by Rosalyn Singleton MD, ANTHC Slides adapted from original powerpoint by: Carrie L. Byington, MD HA and Edna Benning Presidential Professor of Pediatrics
More informationImmunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H.
Immunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H. Vanderbilt University School of Medicine 1 DISCLOSURES Financial Relationships with Relevant Commercial Interests Receive research funding
More informationKeeping up with immunizations for adults
MEDICAL GRAND ROUNDS CME CREDIT EDUCATIONAL OBJECTIVE: Readers will vaccinate their patients according to guidelines from the US Centers for Disease Control and Prevention CRAIG NIELSEN, MD Associate Professor,
More informationAdult Immunization Update 2015
Adult Immunization Update 2015 Objectives Upon completion of this session, the pharmacist should be able to: Compare and contrast previous versions of the ACIP immunization schedules with the most recent
More informationPreventative Vaccines. Vaccines for Special Populations. Vaccinations for Adults: An Update. Vaccines Generally Available in the U.S.
Vaccinations for Adults: An Update Preventative Vaccines Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted Lisa G. Winston, MD University of California,
More informationPediatric and Adolescent Vaccines
Pediatric and Adolescent Vaccines Andrea A. Berry, M.D. Division of Infectious Diseases and Tropical Pediatrics Center for Vaccine Development & Division of Malaria Research Overview Pediatric vaccine
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Diseases/Pathogens with Vaccines for Special Populations.
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationMark H. Sawyer, MD Professor of Clinical Pediatrics UCSD School of Medicine and Rady Children s Hospital San Diego
Mark H. Sawyer, MD Professor of Clinical Pediatrics UCSD School of Medicine and Rady Children s Hospital San Diego I have no relevant financial relationships with the manufacturer(s) of any commercial
More informationCHAMPS 2012 Immunization Update
CHAMPS 2012 Immunization Update with Iyabode A. Beysolow, M.D., M.P.H. National Center for Immunization and Respiratory Diseases Teleconference (HRSA Region VIII) July 25, 2012 7/19/2012 Disclosures Dr.
More informationVaccines for Primary Care Pneumococcal, Shingles, Pertussis
Vaccines for Primary Care Pneumococcal, Shingles, Pertussis Devang Patel, M.D. Assistant Professor Chief of Service, MICU ID Service University of Maryland School of Medicine Pneumococcal Vaccine Pneumococcal
More informationStreptococcus pneumoniae CDC
Streptococcus pneumoniae CDC Pneumococcal Disease Infection caused by the bacteria, Streptococcus pneumoniae» otitis media 20 million office visits (28-55% Strep)» pneumonia 175,000 cases annually» meningitis
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationAdult Immunization Update April 2016
Adult Immunization Update April 2016 C. Wayne Weart, Pharm D, FASHP, FAPhA, BCPS Professor of Clinical Pharmacy and Outcome Sciences South Carolina College of Pharmacy Professor of Family Medicine Medical
More informationACIP Meeting Update, New Recommendations and Pending Influenza Season
ACIP Meeting Update, New Recommendations and Pending Influenza Season February 17 th 2011 www.immunizetexas.com ACIP Upcoming Agenda and New Recommendations ACIP (February 23-24 th 2011) Topics for meeting
More informationMandates and More. Julie Morita, M.D. Deputy Commissioner Chicago Department of Public Health. Chicago Department of Public Health
Mandates and More Julie Morita, M.D. Deputy Chicago Department of Public Health Why are vaccines required for school entry? School Vaccine Requirements Small pox vaccine required in Massachusetts 1855
More informationImmunizations: new and sometimes confusing recommendations MARK H. SAWYER, MD UCSD SCHOOL OF MEDICINE AND RADY CHILDREN S HOSPITAL SAN DIEGO
Immunizations: new and sometimes confusing recommendations MARK H. SAWYER, MD UCSD SCHOOL OF MEDICINE AND RADY CHILDREN S HOSPITAL SAN DIEGO Disclosures I have no financial disclosures related to this
More informationMeningococcal Update. Disclosure. Meningococal and Influenza Vaccines Update! Robert Wittler, MD Sept 12, 2014 KAAP Fall CME Meeting
1 Meningococal and Influenza Vaccines Update! Robert Wittler, MD Sept 12, 2014 KAAP Fall CME Meeting 2 Disclosure Speakers Bureau: Sanofi Pasteur Vaccines and Novartis! I do not intend to discuss an unapproved/
More informationUpdate on Immunizations H. Keipp Talbot, M.D., M.P.H.
Update on Immunizations H. Keipp Talbot, M.D., M.P.H. Vanderbilt University Medical Center 1 DISCLOSURES Financial Relationships with Relevant Commercial Interests Receive research funding from Sanofi
More informationImmunizations Updates in Family Medicine 2017
Immunizations Updates in Family Medicine 2017 Joyce Sanchez, MD, FACP Assistant Professor of Medicine Division of Infectious Diseases 2017 MFMER slide-1 No disclosures 2017 MFMER slide-2 Learning Objectives
More informationKatherine Julian, MD July 1, Vaccines Generally Available in the U.S. U.S.
Katherine Julian, MD July 1, 2008 Vaccines Generally Available in the U.S. Vaccines Generally Available in the U.S. Vaccines for Special Populations Plague Tularemia Smallpox Anthrax Botulism Tuberculosis
More informationImmuniza(on Update Disclosures. Learning Objec(ves 4/9/15
Immuniza(on Update 2015 Jayme Garcia, PharmD Community Pharmacy Resident Smith s Food & Drug Disclosures Dr. Garcia declares no conflicts of interest, real or apparent, and no financial interests in any
More informationUPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES
DISCLOSURES UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES Nothing to disclose Kylie Mueller, Pharm.D., BCPS Clinical Specialist, Infectious Diseases Spartanburg Regional Medical Center LEARNING OBJECTIVES
More informationImmunization Guidelines for the Use of State Supplied Vaccine April 18, 2013
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationVaccines and Adults: Our Collective Challenge Webinar
Vaccines and Adults: Our Collective Challenge Webinar Questions 1. What documentation would a pediatrician need to immunize adult parents to avoid some risk since they are non-patients of the practice
More information9/12/2018. Meningococcal Disease and Meningococcal Vaccine. Neisseria meningitidis. Meningococcal Disease Pathogenesis. Aerobic gram-negative bacteria
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Meningococcal Disease and Meningococcal Vaccine Adult Track Chapter 14 Photographs and images included
More informationAdult Vaccine Update. NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH
Adult Vaccine Update NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH Summary points: Canadian adults > 18 should be regularly assessed to ensure recommended vaccinations are up
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Diseases/Pathogens with Vaccines for Special Populations
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationImmunization Update 2016
Immunization Update 2016 Candice L. Robinson Medical Officer Immunization Services Division New Hampshire Immunization Conference Manchester, NH March 23, 2016 Disclosures Candice Robinson is a federal
More information10/16/2018. Be Discuss. Describe. Discuss. Discuss 2018 ADULT IMMUNIZATION SCHEDULE INFLUENZA ADULT IMMUNIZATION UPDATE TRAINING OBJECTIVES FLUMIST
ADULT IMMUNIZATION UPDATE NORTH DAKOTA ACADEMY OF FAMILY PHYSICIANS NOVEMBER 10, 2018 Be Discuss Upon completion of the adult immunization training, participants will be able to: Discuss the general adult
More information10/12/2016. Disclosures. Immunization Update Disclosures
Immunization Update 2016 JoEllen Wolicki, BSN, RN Nurse Educator Immunization Services Division 2016 Professional Immunization Seminar Erie, Pennsylvania October 20, 2016 National Center for Immunization
More informationWhat are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
More informationDOES YOUR IMMUNIZATION KNOWLEDGE NEED A BOOSTER?: UPDATES FOR 2014
DOES YOUR IMMUNIZATION KNOWLEDGE NEED A BOOSTER?: UPDATES FOR 2014 Brandon Dionne, PharmD PGY2 Pharmacy Resident In Infectious Diseases University Of New Mexico College Of Pharmacy OBJECTIVES Explain general
More information10/4/2014 DOES YOUR IMMUNIZATION KNOWLEDGE NEED A BOOSTER?: UPDATES FOR 2014 OBJECTIVES CASE 1 IMMUNIZATION PRINCIPLES CASE 2
DOES YOUR IMMUNIZATION KNOWLEDGE NEED A BOOSTER?: UPDATES FOR 2014 Brandon Dionne, PharmD PGY2 Pharmacy Resident In Infectious Diseases University Of New Mexico College Of Pharmacy OBJECTIVES Explain general
More informationHot topics in immunization American Pharmacists Association
CPE Hot topics in immunization American Pharmacists Association Abstract Objectives: To describe recent changes in recommended immunization practices, including the introduction of new vaccines, and to
More informationPennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016
Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016 Disclosures: Immunizations Donald Middleton, MD & Richard Zimmerman,
More informationMOLINA HEALTHCARE OF TEXAS
MOLINA HEALTHCARE OF TEXAS Preventive Care Guidelines: Ages 21 and Older GUIDELINE Molina Healthcare of Texas has adopted Preventive Care Guidelines: Ages 21 and Older. The guideline was reviewed and adopted
More informationImmunization Guidelines for the Use of State Supplied Vaccine May 17, 2015
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationEileen Yamada, MD, MPH CDPH Immunization Branch
Eileen Yamada, MD, MPH CDPH Immunization Branch Eileen.Yamada@cdph.ca.gov Disclosures I have no financial conflict of interest with any of the vaccine products that I will be discussing today. Any discussion
More informationAn Update on Pediatric Vaccines
Faculty Disclosure An Update on Pediatric Vaccines I have not had any relevant financial relationships with resulting commercial interests or conflicts of interest in the past 12 months. Rhya Strifling,
More informationImmunization Update 2013 Across the Lifespan
Immunization Update 2013 Across the Lifespan Andrew Kroger M.D., M.P.H. Medical Officer, Centers for Disease Control and Prevention New York State Association of County Health Officials (NYSACHO) New York
More informationImmunizations: Recommendations, Controversies, and Public Perception MARK H. SAWYER, MD RADY CHILDREN S HOSPITAL
Immunizations: Recommendations, Controversies, and Public Perception MARK H. SAWYER, MD UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL Vaccination is the top Public Health achievement of the 20th Century
More informationSummary of Recommendations for Adult Immunization (Age 19 years and older) PAGE 1 OF 5
Summary of Recommendations for Adult Immunization (Age 19 years and older) PAGE 1 OF 5 Influenza Inactivated Influenza vaccine (IIV*) or ID (intradermally) * includes recombinant influenza vaccine (RIV3)
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years United States, 2014. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations
More informationPARTICIPANT HANDOUTS 2015 Immunization Update
PARTICIPANT HANDOUTS 2015 Immunization Update PRESENTER Donna Weaver, RN, MN, Nurse Educator, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC)
More informationVaccines Generally Available in the U.S. Vaccines Generally Available in the U.S. 8/5/2013
Katherine Julian, MD Professor of Clinical Medicine, UCSF August 5, 2013 Vaccines Generally Available in the U.S. Tetanus Diptheria Pertussis Measles Mumps Rubella Varicella Meningococcus Pneumococcus
More information2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle
2013 Adult Immunization Update David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Adult Immunization Update Pertussis Vaccine Influenza Vaccine Zoster
More information